Top news of the day from across the health care landscape.
A 2-year hepatitis A outbreak in San Diego, California, has ended, the Associated Press reported. According to the article, San Diego County health authorities have declared an end to the outbreak, which killed 20 individuals and sickened approximately 600. Investigators determined that the first likely case of the outbreak occurred during the week of November 22, 2016, and the cost of fighting it was estimated at more than $12 million, the article reported.
A study by GlaxoSmithKlime showed that an experimental once-monthly 2-drug injection to control HIV was just as effective as a daily 3-drug oral regimen, Reuters reported. According to the article, cabotegravir and rilpivirine was shown to suppress the HIV virus in a cohort of adults who had not been on a long-established daily 3-drug oral regimen. The results support an earlier major study, which involved adults who had been using a 3-drug oral regimen to control the virus, the article reported.
The CDC confirmed 10 more cases of a rare neurological condition, acute flaccid myelitis, across 24 states, Reuters reported. According to the article, the CDC confirmed approximately 62 cases of acute flaccid myelitis earlier this month, with most of the cases reported so far being children. In a health advisory, the CDC said it recently received increased reports of patients with symptoms of the disease over the last 3 months, the article reported.